Dr. Margarete Fischer-Bosch-Institut für Klinische Pharmakologie
Research facility
Location:
Stuttgart,
Germany (DE)
ISNI: 000000040561903X
ROR: https://ror.org/02pnjnj33
Show on Map:
Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin (2018)
Schaeffeler E, Büttner F, Reustle A, Klumpp V, Winter S, Rausch S, Fisel P, et al.
Journal article
Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21 (2016)
Hamdi Y, Soucy P, Adoue V, Michailidou K, Canisius S, Lemacon A, Droit A, et al.
Journal article
Dihydrocodeine: a new opioid substrate for the polymorphic CYP2D6 in humans. (1995)
Fromm M, Hofmann U, Griese U, Mikus G
Journal article, Original article